missing translation for 'onlineSavingsMsg'
Learn More
Learn More
This item is not returnable.
View return policy
Description
The B27 antibody reacts with human interferon-γ (IFN-γ). The immunogen used to generate the B27 hybridoma was E.coli-expressed recombinant human IFN-γ. This is a neutralizing antibody. The use of B27 antibody for epitope mapping of human IFN-γ has been described. The B27 antibody has been reported not to bind to denatured IFN-γ. This antibody is routinely tested as a blocking control for intracellular staining. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.
Specifications
| IFN-γ | |
| Monoclonal | |
| 0.5mg/mL | |
| Aqueous buffered solution containing ≤0.09% sodium azide. | |
| Human E.coli-expressed IFN-γ | |
| 0.25 mg | |
| Immunology | |
| Human | |
| IgG1 κ |
| Immunocytochemistry | |
| B27 | |
| Unconjugated | |
| Mouse | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Store undiluted at 4°C |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only.
Spot an opportunity for improvement?Share a Content Correction